GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Spexis AG (XSWX:SPEX) » Definitions » Other Current Liabilities

Spexis AG (XSWX:SPEX) Other Current Liabilities : CHF2.88 Mil (As of Jun. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Spexis AG Other Current Liabilities?

Spexis AG's other current liabilities for the quarter that ended in Jun. 2023 was CHF2.88 Mil.

Spexis AG's quarterly other current liabilities declined from Jun. 2022 (CHF4.55 Mil) to Dec. 2022 (CHF3.01 Mil) and declined from Dec. 2022 (CHF3.01 Mil) to Jun. 2023 (CHF2.88 Mil).

Spexis AG's annual other current liabilities increased from Dec. 2020 (CHF3.24 Mil) to Dec. 2021 (CHF4.95 Mil) but then declined from Dec. 2021 (CHF4.95 Mil) to Dec. 2022 (CHF3.01 Mil).

Spexis AG Other Current Liabilities Historical Data

The historical data trend for Spexis AG's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Spexis AG Other Current Liabilities Chart

Spexis AG Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Spexis AG Semi-Annual Data
Dec13 Dec14 Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Spexis AG Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Spexis AG Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Spexis AG's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Spexis AG (XSWX:SPEX) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Spexis AG (XSWX:SPEX) » Definitions » Other Current Liabilities
Comparable Companies
XSWX:OBSN XSWX:EVE XSWX:ADXN XSWX:KNRS XSWX:RLF OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX BGNE SZSE:300122 ALNY OCSE:GMAB XKRX:068270
Traded in Other Exchanges
SPEXz:UK
Address
Hegenheimermattweg 125, Allschwil, CHE, CH-4123
Website
https://www.polyphor.com
Spexis AG is a clinical-stage biopharmaceutical company. The company is engaged in the discovery and development of antibiotics and other specialty pharma products for severe or life-threatening diseases. The company's lead product, murepavadin, is in Phase III development against Pseudomonas aeruginosa - recognized as a critical priority 1 pathogen by World Health Organization. It has one operating segment focusing on the research and development and prospective commercialization of respiratory therapeutics addressing high unmet medical needs.

Spexis AG (XSWX:SPEX) Headlines

No Headlines